Knud Jepsen

Knud Jepsen A/S, operating under the global brand Queen®, is a leading Danish plant biotechnology company specializing in the breeding and production of Kalanchoe and therapeutic crops. The company leverages advanced genomic selection, tissue culture, and molecular breeding techniques to develop plants with high longevity and specific chemical profiles. In the life sciences sector, Knud Jepsen has transitioned its horticultural expertise into the medical cannabis market, focusing on the standardized production of cannabinoids under Good Agricultural and Collection Practices (GACP) and GMP standards. Through its Queen Genetics division, the company provides proprietary genetics and licensing to international partners. Their R&D efforts are centered on optimizing plant-derived bioactive compounds for pharmaceutical and therapeutic applications.